Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $3 Million - $4.19 Million
-68,767 Reduced 89.58%
8,003 $431,000
Q2 2022

Jul 20, 2022

SELL
$28.82 - $77.35 $8.81 Million - $23.6 Million
-305,554 Reduced 79.92%
76,770 $3.1 Million
Q1 2022

Apr 14, 2022

SELL
$48.25 - $100.49 $3.11 Million - $6.48 Million
-64,510 Reduced 14.44%
382,324 $25.3 Million
Q4 2021

Jan 19, 2022

BUY
$88.71 - $120.43 $10.8 Million - $14.7 Million
121,663 Added 37.42%
446,834 $44.7 Million
Q3 2021

Oct 19, 2021

SELL
$98.77 - $132.17 $3.12 Million - $4.17 Million
-31,580 Reduced 8.85%
325,171 $40.7 Million
Q2 2021

Aug 09, 2021

SELL
$109.77 - $165.68 $5 Million - $7.55 Million
-45,590 Reduced 11.33%
356,751 $44.3 Million
Q1 2021

May 13, 2021

BUY
$127.04 - $179.1 $14.1 Million - $19.9 Million
110,954 Added 38.08%
402,341 $61.4 Million
Q4 2020

Jan 19, 2021

SELL
$99.96 - $135.93 $7.77 Million - $10.6 Million
-77,713 Reduced 21.05%
291,387 $37.6 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $12.1 Million - $16.8 Million
150,179 Added 68.6%
369,100 $41.3 Million
Q2 2020

Jul 17, 2020

BUY
$60.49 - $97.5 $7.44 Million - $12 Million
122,924 Added 128.05%
218,921 $17.8 Million
Q1 2020

Apr 16, 2020

BUY
$59.04 - $88.81 $660,362 - $993,339
11,185 Added 13.19%
95,997 $6.68 Million
Q4 2019

Feb 14, 2020

BUY
$59.49 - $82.78 $4.62 Million - $6.43 Million
77,722 Added 1096.22%
84,812 $6.63 Million
Q3 2019

Nov 14, 2019

SELL
$62.59 - $110.3 $469,925 - $828,132
-7,508 Reduced 51.43%
7,090 $453,000
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $933,396 - $1.33 Million
14,598 New
14,598 $1.26 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.